Investor Presentaiton
Investor Presentation
First six months of 2018
The GLP-1 segment accounts for 13% of the global
diabetes care market value
Slide 61
Global GLP-1 market
GLP-1 value
in DKK
billion
VictozaⓇ
exenatide
dulaglutide
Ozempic®
other
Share of total
diabetes care
market
GLP-1 value and patient share of the total
diabetes care market
Share of total
diabetes care
GLP-1 value share of total diabetes
GLP-1 patient share¹ of total diabetes
market
70
10%
20%
60
15%
8%
CAGR value¹: 33.8%
15%
50
13%
11%
6%
40
10%
30
4%
7%
6%
5%
20
5%
5%
2%
3%
10
1%
0
0%
0%
May
2013
May
2018
World North Reg Reg Reg Reg Reg
America EU LATAM J&K AAMEO China
1 CAGR for 5-year period
Source: IQVIA monthly MAT May, 2018 value figures (DKK)
changing
diabetes®
Reg: Region; AAMEO: Africa, Asia, Middle-East and Oceania; J&K: Japan & Korea; LATAM: Latin America.
1 Patient share is indicative and based on data for US, UK, Germany and France only.
Source: Value data; IQVIA monthly MAT May, 2018. Patient data; IQVIA Disease Analyser (DE, FR, UK),
QuintilesIQVIA LRX (USA), May 2018View entire presentation